134 related articles for article (PubMed ID: 20224929)
1. Biological and clinical implications of nicastrin expression in invasive breast cancer.
Filipović A; Gronau JH; Green AR; Wang J; Vallath S; Shao D; Rasul S; Ellis IO; Yagüe E; Sturge J; Coombes RC
Breast Cancer Res Treat; 2011 Jan; 125(1):43-53. PubMed ID: 20224929
[TBL] [Abstract][Full Text] [Related]
2. Nicastrin and Notch4 drive endocrine therapy resistance and epithelial to mesenchymal transition in MCF7 breast cancer cells.
Lombardo Y; Faronato M; Filipovic A; Vircillo V; Magnani L; Coombes RC
Breast Cancer Res; 2014 Jun; 16(3):R62. PubMed ID: 24919951
[TBL] [Abstract][Full Text] [Related]
3. Nicastrin regulates breast cancer stem cell properties and tumor growth in vitro and in vivo.
Lombardo Y; Filipović A; Molyneux G; Periyasamy M; Giamas G; Hu Y; Trivedi PS; Wang J; Yagüe E; Michel L; Coombes RC
Proc Natl Acad Sci U S A; 2012 Oct; 109(41):16558-63. PubMed ID: 23012411
[TBL] [Abstract][Full Text] [Related]
4. Anti-nicastrin monoclonal antibodies elicit pleiotropic anti-tumour pharmacological effects in invasive breast cancer cells.
Filipović A; Lombardo Y; Faronato M; Abrahams J; Aboagye E; Nguyen QD; d'Aqua BB; Ridley A; Green A; Rahka E; Ellis I; Recchi C; Przulj N; Sarajlić A; Alattia JR; Fraering P; Deonarain M; Coombes RC
Breast Cancer Res Treat; 2014 Nov; 148(2):455-62. PubMed ID: 25248409
[TBL] [Abstract][Full Text] [Related]
5. Breast carcinomas that co-express E- and P-cadherin are associated with p120-catenin cytoplasmic localisation and poor patient survival.
Paredes J; Correia AL; Ribeiro AS; Milanezi F; Cameselle-Teijeiro J; Schmitt FC
J Clin Pathol; 2008 Jul; 61(7):856-62. PubMed ID: 18381381
[TBL] [Abstract][Full Text] [Related]
6. LAPTM4B Predicts Axillary Lymph Node Metastasis in Breast Cancer and Promotes Breast Cancer Cell Aggressiveness in Vitro.
Xiao M; Yang S; Meng F; Qin Y; Yang Y; Jia S; Cai X; Li C; Huang Y; Ning X
Cell Physiol Biochem; 2017; 41(3):1072-1082. PubMed ID: 28245476
[TBL] [Abstract][Full Text] [Related]
7. S-palmitoylation of gamma-secretase subunits nicastrin and APH-1.
Cheng H; Vetrivel KS; Drisdel RC; Meckler X; Gong P; Leem JY; Li T; Carter M; Chen Y; Nguyen P; Iwatsubo T; Tomita T; Wong PC; Green WN; Kounnas MZ; Thinakaran G
J Biol Chem; 2009 Jan; 284(3):1373-84. PubMed ID: 19028695
[TBL] [Abstract][Full Text] [Related]
8. Glycoprotein 90K Promotes E-Cadherin Degradation in a Cell Density-Dependent Manner via Dissociation of E-Cadherin-p120-Catenin Complex.
Park SY; Yoon S; Sun EG; Zhou R; Bae JA; Seo YW; Chae JI; Paik MJ; Ha HH; Kim H; Kim KK
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29207493
[TBL] [Abstract][Full Text] [Related]
9. E-cadherin/p120-catenin and tetraspanin Co-029 cooperate for cell motility control in human colon carcinoma.
Greco C; Bralet MP; Ailane N; Dubart-Kupperschmitt A; Rubinstein E; Le Naour F; Boucheix C
Cancer Res; 2010 Oct; 70(19):7674-83. PubMed ID: 20858717
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of phosphatidylcholine-specific phospholipase C results in loss of mesenchymal traits in metastatic breast cancer cells.
Abalsamo L; Spadaro F; Bozzuto G; Paris L; Cecchetti S; Lugini L; Iorio E; Molinari A; Ramoni C; Podo F
Breast Cancer Res; 2012 Mar; 14(2):R50. PubMed ID: 22429397
[TBL] [Abstract][Full Text] [Related]
11. Transmembrane protein 92 performs a tumor-promoting function in breast carcinoma by contributing to the cell growth, invasion, migration and epithelial-mesenchymal transition.
Lin MZ; Teng LL; Sun XL; Zhang LP; Chen F; Yu LJ
Tissue Cell; 2020 Dec; 67():101415. PubMed ID: 32835947
[TBL] [Abstract][Full Text] [Related]
12. Loss of E-cadherin promotes migration and invasion of cholangiocarcinoma cells and serves as a potential marker of metastasis.
Techasen A; Loilome W; Namwat N; Khuntikeo N; Puapairoj A; Jearanaikoon P; Saya H; Yongvanit P
Tumour Biol; 2014 Sep; 35(9):8645-52. PubMed ID: 24867095
[TBL] [Abstract][Full Text] [Related]
13. [Epithelial cadherins and associated molecules in invasive lobular breast cancer].
Brilliant YM; Brilliant AA; Sazonov SV
Arkh Patol; 2017; 79(1):12-18. PubMed ID: 28295003
[TBL] [Abstract][Full Text] [Related]
14. ROR2 promotes the epithelial-mesenchymal transition by regulating MAPK/p38 signaling pathway in breast cancer.
Xu J; Shi J; Tang W; Jiang P; Guo M; Zhang B; Ma G
J Cell Biochem; 2020 Oct; 121(10):4142-4153. PubMed ID: 32048761
[TBL] [Abstract][Full Text] [Related]
15. Epithelial Paradox: Clinical Significance of Coexpression of E-cadherin and Vimentin With Regard to Invasion and Metastasis of Breast Cancer.
Yamashita N; Tokunaga E; Iimori M; Inoue Y; Tanaka K; Kitao H; Saeki H; Oki E; Maehara Y
Clin Breast Cancer; 2018 Oct; 18(5):e1003-e1009. PubMed ID: 29526677
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase C α enhances migration of breast cancer cells through FOXC2-mediated repression of p120-catenin.
Pham TND; Perez White BE; Zhao H; Mortazavi F; Tonetti DA
BMC Cancer; 2017 Dec; 17(1):832. PubMed ID: 29216867
[TBL] [Abstract][Full Text] [Related]
17. Identification of a tetratricopeptide repeat-like domain in the nicastrin subunit of γ-secretase using synthetic antibodies.
Zhang X; Hoey RJ; Lin G; Koide A; Leung B; Ahn K; Dolios G; Paduch M; Ikeuchi T; Wang R; Li YM; Koide S; Sisodia SS
Proc Natl Acad Sci U S A; 2012 May; 109(22):8534-9. PubMed ID: 22586122
[TBL] [Abstract][Full Text] [Related]
18. Interplay between neural-cadherin and vascular endothelial-cadherin in breast cancer progression.
Rezaei M; Friedrich K; Wielockx B; Kuzmanov A; Kettelhake A; Labelle M; Schnittler H; Baretton G; Breier G
Breast Cancer Res; 2012 Dec; 14(6):R154. PubMed ID: 23216791
[TBL] [Abstract][Full Text] [Related]
19. Altered localization of p120 catenin during epithelial to mesenchymal transition of colon carcinoma is prognostic for aggressive disease.
Bellovin DI; Bates RC; Muzikansky A; Rimm DL; Mercurio AM
Cancer Res; 2005 Dec; 65(23):10938-45. PubMed ID: 16322241
[TBL] [Abstract][Full Text] [Related]
20. Γ-secretase components as predictors of breast cancer outcome.
Peltonen HM; Haapasalo A; Hiltunen M; Kataja V; Kosma VM; Mannermaa A
PLoS One; 2013; 8(11):e79249. PubMed ID: 24223915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
